| Entry |
|
|---|
| Symbol |
PPP3CC
|
|---|
| Name |
(RefSeq) serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X2
|
|---|
| KO |
| K04348 | serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16] |
|
|---|
| Organism |
shr Sarcophilus harrisii (Tasmanian devil)
|
|---|
| Pathway |
| shr04625 | C-type lectin receptor signaling pathway |
| shr04650 | Natural killer cell mediated cytotoxicity |
| shr04658 | Th1 and Th2 cell differentiation |
| shr04660 | T cell receptor signaling pathway |
| shr04662 | B cell receptor signaling pathway |
| shr05022 | Pathways of neurodegeneration - multiple diseases |
| shr05163 | Human cytomegalovirus infection |
| shr05166 | Human T-cell leukemia virus 1 infection |
| shr05167 | Kaposi sarcoma-associated herpesvirus infection |
| shr05170 | Human immunodeficiency virus 1 infection |
| shr05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
|
|---|
| Brite |
KEGG Orthology (KO) [BR:shr00001]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
100915297 (PPP3CC)
04310 Wnt signaling pathway
100915297 (PPP3CC)
04370 VEGF signaling pathway
100915297 (PPP3CC)
04020 Calcium signaling pathway
100915297 (PPP3CC)
04022 cGMP-PKG signaling pathway
100915297 (PPP3CC)
09140 Cellular Processes
09143 Cell growth and death
04114 Oocyte meiosis
100915297 (PPP3CC)
04218 Cellular senescence
100915297 (PPP3CC)
09150 Organismal Systems
09151 Immune system
04625 C-type lectin receptor signaling pathway
100915297 (PPP3CC)
04650 Natural killer cell mediated cytotoxicity
100915297 (PPP3CC)
04660 T cell receptor signaling pathway
100915297 (PPP3CC)
04658 Th1 and Th2 cell differentiation
100915297 (PPP3CC)
04659 Th17 cell differentiation
100915297 (PPP3CC)
04662 B cell receptor signaling pathway
100915297 (PPP3CC)
09152 Endocrine system
04922 Glucagon signaling pathway
100915297 (PPP3CC)
04921 Oxytocin signaling pathway
100915297 (PPP3CC)
04924 Renin secretion
100915297 (PPP3CC)
09156 Nervous system
04724 Glutamatergic synapse
100915297 (PPP3CC)
04728 Dopaminergic synapse
100915297 (PPP3CC)
04720 Long-term potentiation
100915297 (PPP3CC)
09158 Development and regeneration
04360 Axon guidance
100915297 (PPP3CC)
04380 Osteoclast differentiation
100915297 (PPP3CC)
09160 Human Diseases
09161 Cancer: overview
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
100915297 (PPP3CC)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
100915297 (PPP3CC)
05170 Human immunodeficiency virus 1 infection
100915297 (PPP3CC)
05163 Human cytomegalovirus infection
100915297 (PPP3CC)
05167 Kaposi sarcoma-associated herpesvirus infection
100915297 (PPP3CC)
09171 Infectious disease: bacterial
05152 Tuberculosis
100915297 (PPP3CC)
09164 Neurodegenerative disease
05010 Alzheimer disease
100915297 (PPP3CC)
05014 Amyotrophic lateral sclerosis
100915297 (PPP3CC)
05020 Prion disease
100915297 (PPP3CC)
05022 Pathways of neurodegeneration - multiple diseases
100915297 (PPP3CC)
09165 Substance dependence
05031 Amphetamine addiction
100915297 (PPP3CC)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
100915297 (PPP3CC)
09180 Brite Hierarchies
09181 Protein families: metabolism
01009 Protein phosphatases and associated proteins [BR:shr01009]
100915297 (PPP3CC)
Enzymes [BR:shr01000]
3. Hydrolases
3.1 Acting on ester bonds
3.1.3 Phosphoric-monoester hydrolases
3.1.3.16 protein-serine/threonine phosphatase
100915297 (PPP3CC)
Protein phosphatases and associated proteins [BR:shr01009]
Protein serine/threonine phosphatases
Phosphoprotein phosphatases (PPPs)
Calcineurin (PPP3/ PP2B)
Catalytic subunits
100915297 (PPP3CC)
|
|---|
| SSDB |
|
|---|
| Motif |
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| Position |
2:135073058..135197911
|
|---|
| AA seq |
535 aa
MSSRTRNKLSTTERVIKAVPFPPTRRLTIKEVFEDGKPRLDVLKSHLVKEGRLEEEAALK
IINDGGAILKSEKTMIELEAPITVCGDVHGQFFDLMKLFEVGGSPVNTRYLFLGDYVDRG
YFSIECVLYLWSLKIHHPRTFFLLRGNHECRHLTEYFTFRQECRIKYSEQIYDACMDTFD
CLPLAALLNQQFLCVHGGLSPEINSLDDIRRLDRFREPPAFGPMCDLLWSDPLEDYGSEK
TMEHFSHNTVRGCSYFYSYPAVCEFLQSNSLLSVIRAHEAQDSGYRMYRKSQTTGFPSLI
TIFSAPNYLDVYNNKAAVLKYENNIMNIRQFNCSPHPYWLPNFMDVFTWSLPFVGEKVTE
MLVNILNICSDDELISDGEETLEGAASLRKEIIRNKIRAIGKMARVFAILREERESVLTL
KGLTPTGTLPLGVLSGGKQTIQLAIRGFSPPHKIRSFEEARGLDRINERMPPRRDKSFPE
GPVAVPANIVSSRSGSKGSSVTKGSSVTKGSSVTKGSSVTKGSSMTKGSTSKKSQ |
|---|
| NT seq |
1608 nt +upstreamnt +downstreamnt
atgtcctcgaggactcgcaacaaactctctaccaccgagcgcgtcatcaaagctgttcct
tttcctccaactcggcggctcacaataaaagaagtatttgaagatggtaaacccagactt
gatgtcttgaaaagccacttggtgaaagaaggtagactagaggaggaagcagccttaaag
ataatcaatgatggaggtgccattctgaaaagtgaaaagactatgatagaattggaggca
cctatcacagtgtgtggtgatgttcatggacaattctttgacctgatgaaattgtttgaa
gttggaggatcacctgttaacacacgctacctcttcctgggagactatgtggatagaggc
tacttcagtatagagtgtgtgctgtacttatggagtttaaaaattcatcatcccagaacg
tttttcctgcttcgcggcaaccatgaatgcaggcatctcacagaatacttcactttcaga
caggaatgtcgaatcaaatattcagaacagatatatgatgcgtgcatggatacatttgat
tgtcttcctcttgctgctctcttaaaccagcagtttttgtgtgtacatggaggactgtct
ccagaaatcaattctttagatgacattaggagattagacaggtttagggaacctccagct
tttggaccaatgtgtgacctgctttggtctgatcccttggaggactatggcagtgagaag
accatggagcactttagccacaacactgtccgagggtgctcctacttttacagttatcct
gcagtttgtgaatttttgcaaagcaatagtttgttatcagtaatcagagcccatgaagct
caagattccgggtatcgaatgtataggaagagccagacaacaggctttccatcactcatt
acaattttctctgccccaaattacctagatgtctataacaacaaagctgctgtactgaaa
tatgagaataatatcatgaacatcagacagtttaactgctctccacacccctattggctt
ccaaactttatggatgtcttcacatggtctttgccttttgttggagagaaagtcaccgag
atgctggttaatattctcaacatatgctctgatgatgagttgatttcagatggtgaggag
acactggaaggagctgcatcacttcgtaaggagatcatcagaaataaaatcagggctatt
ggaaagatggcacgagtgtttgcaattcttcgagaagagagggaaagtgtgctgactctc
aaaggactgactcctacaggtacactacctctgggtgtcctctcaggaggaaagcaaacc
attcaattagcaatccgagggttttcaccccctcacaagatccgaagctttgaggaggct
cggggcctggaccggattaatgagcgcatgccccctcgaagagataaatcattccctgag
gggccagtagcagtgccggcaaatatagtgtcaagccgctcagggtccaagggcagctca
gtgaccaagggcagctcagtgaccaaaggcagctcagtgaccaagggcagctcagtgacc
aagggcagctcaatgaccaagggcagcacgtctaagaaaagccagtaa |
|---|
